FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
F.D.A. Delays Action on Closely Watched Alzheimer’s Drugnews2024-03-08T11:45:07+00:00March 8th, 2024|The New York Times|
New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Declinenews2023-07-17T14:30:32+00:00July 17th, 2023|The New York Times|
